Tesofensine , which affects multiple neurotransmitter systems involved in appetite and metabolism
Patent expiries of blockbuster weight loss GLP-1 (glucagon-like peptide-1) drugs are opening up a sizeable near-term opportunity for Indian pharmaceutical companies in regulated markets, led by Canada and Brazil, with a potential generic market value of about $500 million, according to Vishal Manchanda, Pharma Analyst at Systematix Group
In animal studies, Dihexa was found to be approximately 1,000 times more potent than BDNF (brain-derived neurotrophic factor) at promoting synapse formation
[3] A notable feature of Ipamorelin research is its apparent selectivity and its reported negligible influence on the secretion of other pituitary hormones like cortisol, prolactin, and aldosterone
A broader rollout is expected in 2027
Who can benefit most from regular B12 injections